1.Pseudomyxoma peritonei: Revisited
Mary Grace O. Cheng ; Lylah D. Reyes ; ommel Z. Duenas
Philippine Journal of Obstetrics and Gynecology 2018;42(2):26-34
Bleeding after menopause raises suspicion of malignancy; more
Pseudomyxoma Peritonei
2.A comparison of the efficacy of single-dose Cefazolin versus single-dose Cefazolin plus 7-day Mupirocin ointment wound application in preventing surgical site infection among patients undergoing major Obstetric and Gynecologic procedures at a tertiary university hospital: A single-blinded, randomized controlled trial
Mary Grace O. Cheng ; Lylah D. Reyes ; Jennifer T. Co
Philippine Journal of Obstetrics and Gynecology 2021;45(5):189-195
Background:
Surgical site infection (SSI) is a common complication among all surgical cases. It is the most common nosocomial infection identified in the developing world with pooled incidence of 11.8 per 100 surgical procedures. In our institution, the SSI rate in major obstetric and gynecologic cases in years 2000–2013 is 12.68%.
Objective:
To compare the efficacy of a single-dose cefazolin versus a single dose cefazolin plus 7-day mupirocin ointment wound application in preventing SSI among women undergoing major obstetric and gynecologic abdominal surgical procedures.
Materials and Methods:
The study included are 164 female participants, aged 18–65 years old who underwent major obstetric and gynecologic surgical procedures. Participants were randomly assigned to Groups A and B, wherein all participants were given single dose of 2 g cefazolin, intravenous, 30 min before skin incision. For the participants in Group B, an additional 7-day application of mupirocin ointment on incisional wound during the postoperative period was given. Assessment for occurrence of SSI and healing time using a standardized collection tool and Southampton wound scoring system, respectively, was done on the 8th, 15th, and 30th postoperative days.
Results:
The incidence of SSI is 2.45% (4 out of 164 participants). It was slightly higher in the Cefazolin only arm having three cases, while only one case in the Cefazolin plus mupirocin group. However, the difference of SSI occurrence between the two groups is not statistically significant. Wound healing time was also evaluated which was comparable between treatment groups.
Conclusion
Single dose Cefazolin plus 7-day once daily Mupirocin ointment application is comparable to single dose of cefazolin in preventing SSI in patients undergoing major low-risk obstetric and gynecologic surgeries. Therefore, the addition of mupirocin in uncomplicated major obstetric and gynecologic surgical cases is not cost-beneficial.
Cefazolin
;
Gynecologic Surgical Procedures
;
Mupirocin
;
Obstetric Surgical Procedures
;
Surgical Wound Infection